Ghent University Hospital — Ghent

Public research footprint of Ghent University Hospital, compiled from the ClinicalTrials.gov public registry.

439

Registered studies

140

Active

Recruiting now

243

Completed

Stopped or withdrawn

Most-studied conditions

Leukemia, Myeloid, Acute · Diffuse Large B-cell Lymphoma (DLBCL) · Leukemia, Lymphocytic, Chronic, B-Cell · Metastatic Castration-resistant Prostate Neoplasms

Recently updated registry entries

NCT07332091 — Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator… (Recruiting)
NCT07196722 — A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease (Recruiting)
NCT06852222 — A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Ghent University Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.